RVTY

Revvity, Inc.

HealthcareDiagnostics & ResearchNASDAQ

$87.66

+$2.82 (3.21%)today

Conviction

4/ 10

Fair Value$119.53

Upside+36.36%

Signal14.54

Market Cap$9.5B

52W Range$81.36–$118.30

Next EarningsApr 27

Price History

Bull Case

Queued for analysis

Eagle will generate this view by the next trading session (~7h).

Bear Case

Queued for analysis

Eagle will generate this view by the next trading session (~7h).

Research Feed

analysisMar 26

Conviction: unchanged

RVTY Q4 2025 & 2026 Guidance: Destocking Cycle Over, But 2-3% Organic Growth Is a Low Bar

Q4 2025 beat: revenue M (+6% reported, +4% organic) vs M consensus. 2026 guide: .96-2.99B revenue, adj EPS .35-.45 (beat consensus .32). Biopharma destocking cycle ending; demand returning. But 2-3% o...

sec_10kMar 4

Conviction: unchanged

RVTY FY2025: Weak revenue growth, tariff headwinds, margin compression despite cost cuts

RVTY FY2025 reveals slowing growth (4% revenue) against backdrop of tariff headwinds ($25M cost), margin compression (gross margin -104 bps), and inventory/working capital normalization. Life Sciences...